l-DOPA, also known asl-3,4-dihydroxyphenylalanine and used medically aslevodopa, is made and used as part of the normalbiology of some plants[2] and animals, including humans. Humans, as well as a portion of the other animals that utilizel-DOPA, make it viabiosynthesis from theamino acidl-tyrosine.
![]() Skeletal formula ofL-DOPA | |
![]() | |
Names | |
---|---|
IUPAC name (S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid | |
Other names l-3,4-Dihydroxyphenylalanine; Levodopa | |
Identifiers | |
3D model (JSmol) | |
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.000.405![]() |
EC Number |
|
KEGG | |
UNII | |
| |
| |
Properties | |
C9H11NO4 | |
Molar mass | 197.19 g/mol |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). |
l-DOPA is theprecursor to theneurotransmittersdopamine,norepinephrine (noradrenaline), andepinephrine (adrenaline), which are collectively known ascatecholamines. Furthermore,l-DOPA itself mediatesneurotrophic factor release by the brain and CNS.[3][4] In some plant families (of the orderCaryophyllales),l-DOPA is the central precursor of a biosynthetic pathway that produces a class of pigments calledbetalains.[5]
l-DOPA can be manufactured and in its pure form is sold as adrug with theINNTooltip International Nonproprietary Namelevodopa. Trade names include Sinemet, Pharmacopa, Atamet, and Stalevo. As a drug, it is used in thetreatment ofParkinson's disease anddopamine-responsive dystonia, as well asrestless leg syndrome.[6]
l-DOPA has a counterpart with oppositechirality,d-DOPA. As is true for many molecules, the human body produces only one of theseisomers (thel-DOPA form). Theenantiomeric purity ofl-DOPA may be analyzed by determination of the optical rotation or by chiralthin-layer chromatography.[7]
Biological role
editl-DOPA is produced from the amino acidl-tyrosine by the enzymetyrosine hydroxylase.l-DOPA can act as anl-tyrosine mimetic and be incorporated into proteins by mammalian cells in place ofl-tyrosine, generatingprotease-resistant andaggregate-prone proteinsin vitro and may contribute toneurotoxicity with chronicl-DOPA administration.[11]It is also the precursor for themonoamine orcatecholamine neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline). Dopamine is formed by the decarboxylation ofl-DOPA byaromaticl-amino acid decarboxylase (AADC).
l-DOPA can be directly metabolized bycatechol-O-methyl transferase to3-O-methyldopa, and then further tovanillactic acid. This metabolic pathway is nonexistent in the healthy body, but becomes important after peripherall-DOPA administration in patients with Parkinson's disease or in the rare cases of patients with AADC enzyme deficiency.[12]
l-Phenylalanine,l-tyrosine, andl-DOPA are all precursors to the biologicalpigmentmelanin. The enzymetyrosinasecatalyzes theoxidation ofl-DOPA to the reactive intermediatedopaquinone, which reacts further, eventually leading to melaninoligomers. In addition,tyrosinase can convert tyrosine directly tol-DOPA in the presence of a reducing agent such asascorbic acid.[13]
History
editl-dopa was first islolated from the seeds of theVicia faba orbroad bean plant in 1913 by Swiss biochemist Markus Guggenheim.[14]
The 2001Nobel Prize in Chemistry was also related tol-DOPA: the Nobel Committee awarded one-quarter of the prize toWilliam S. Knowles for his work on chirally catalysedhydrogenation reactions, the most noted example of which was used for the synthesis ofl-DOPA.[15][16][17]
Other organisms
editMarine adhesion
editl-DOPA is a keycompound in the formation ofmarine adhesive proteins, such as those found inmussels.[18][19] It is believed to be responsible for the water-resistance and rapid curing abilities of these proteins.l-DOPA may also be used to prevent surfaces from fouling by bonding antifouling polymers to a susceptiblesubstrate.[20] The versatile chemistry ofl-DOPA can be exploited in nanotechnology.[21] For example, DOPA-containing self-assembling peptides were found to form functional nanostructures, adhesives and gels.[22][23][24][25]
Plants and in the environment
editIn plants, L-DOPA functions as anallelochemical which inhibits the growth of certain species, and is produced and secreted by a few legume species such as the broad beanVicia faba and the velvet beanMucuna pruriens.[26] Its effect is strongly dependent on the pH and the reactivity of iron in the soil.[27] L-DOPA can also be found incephalopod ink.[28]
Use as a medication and supplement
editL-DOPA is used medically under the namelevodopa in the treatment ofParkinson's disease and certain other medical conditions. It is usually used incombination with aperipherally selectivearomaticL-amino acid decarboxylase (AAAD)inhibitor such ascarbidopa orbenserazide. These agents increase the strength and duration of levodopa. Combination formulations includelevodopa/carbidopa andlevodopa/benserazide, as well aslevodopa/carbidopa/entacapone.
L-DOPA is found in high amounts inMucuna pruriens (velvet bean) and is available and usedover-the-counter as asupplement.
References
edit- ^Howard ST, Hursthouse MB, Lehmann CW, Poyner EA (1995). "Experimental and theoretical determination of electronic properties in Ldopa".Acta Crystallogr. B.51 (3):328–337.Bibcode:1995AcCrB..51..328H.doi:10.1107/S0108768194011407.S2CID 96802274.
- ^Cohen PA, Avula B, Katragunta K, Khan I (October 2022)."Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database".JAMA Neurology.79 (10):1085–1086.doi:10.1001/jamaneurol.2022.2184.PMC 9361182.PMID 35939305.
- ^Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS (September 2008)."L-DOPA is an endogenous ligand for OA1".PLOS Biology.6 (9): e236.doi:10.1371/journal.pbio.0060236.PMC 2553842.PMID 18828673.
- ^Hiroshima Y, Miyamoto H, Nakamura F, Masukawa D, Yamamoto T, Muraoka H, et al. (January 2014)."The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii".British Journal of Pharmacology.171 (2):403–14.doi:10.1111/bph.12459.PMC 3904260.PMID 24117106.
- ^Polturak G, Breitel D, Grossman N, Sarrion-Perdigones A, Weithorn E, Pliner M, et al. (2016)."Elucidation of the first committed step in betalain biosynthesis enables the heterologous engineering of betalain pigments in plants".New Phytol.210 (1):269–283.doi:10.1111/nph.13796.PMID 26683006.
- ^Scholz H, Trenkwalder C, Kohnen R, Kriston L, Riemann D, Hornyak M (15 February 2011)."Levodopa for the treatment of restless legs syndrome".Cochrane Database of Systematic Reviews.2011 (5): CD005504.doi:10.1002/14651858.CD005504.pub2.PMC 8889887.PMID 21328278.S2CID 196338172.
- ^Martens J, Günther K, Schickedanz M (1986). "Resolution of Optical Isomers by Thin-Layer Chromatography: Enantiomeric Purity of Methyldopa".Arch. Pharm.319 (6):572–574.doi:10.1002/ardp.19863190618.S2CID 97903386.
- ^Broadley KJ (March 2010). "The vascular effects of trace amines and amphetamines".Pharmacology & Therapeutics.125 (3):363–375.doi:10.1016/j.pharmthera.2009.11.005.PMID 19948186.
- ^Lindemann L, Hoener MC (May 2005). "A renaissance in trace amines inspired by a novel GPCR family".Trends in Pharmacological Sciences.26 (5):274–281.doi:10.1016/j.tips.2005.03.007.PMID 15860375.
- ^Wang X, Li J, Dong G, Yue J (February 2014). "The endogenous substrates of brain CYP2D".European Journal of Pharmacology.724:211–218.doi:10.1016/j.ejphar.2013.12.025.PMID 24374199.
- ^Rodgers KJ (March 2014). "Non-protein amino acids and neurodegeneration: the enemy within".Experimental Neurology.253:192–196.doi:10.1016/j.expneurol.2013.12.010.PMID 24374297.S2CID 2288729.
- ^Hyland K, Clayton PT (December 1992)."Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology"(PDF).Clinical Chemistry.38 (12):2405–10.doi:10.1093/clinchem/38.12.2405.PMID 1281049. Archived fromthe original(PDF) on 7 June 2011. Retrieved16 October 2008.
- ^Ito S, Kato T, Shinpo K, Fujita K (September 1984)."Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-3,4-dihydroxyphenylalanine".The Biochemical Journal.222 (2):407–11.doi:10.1042/bj2220407.PMC 1144193.PMID 6433900.
- ^Ovallath S, Sulthana B (2017)."Levodopa: History and Therapeutic Applications".Annals of Indian Academy of Neurology.20 (3):185–189.doi:10.4103/aian.AIAN_241_17.PMC 5586109.PMID 28904446.
- ^Knowles WS (1983). "Asymmetric hydrogenation".Accounts of Chemical Research.16 (3):106–112.doi:10.1021/ar00087a006.
- ^"Synthetic scheme for total synthesis of DOPA, L- (Monsanto)". UW Madison, Department of Chemistry. Retrieved30 September 2013.
- ^Knowles WS (March 1986). "Application of organometallic catalysis to the commercial production of L-DOPA".Journal of Chemical Education.63 (3): 222.Bibcode:1986JChEd..63..222K.doi:10.1021/ed063p222.
- ^Waite JH, Andersen NH, Jewhurst S, Sun C (2005). "Mussel Adhesion: Finding the Tricks Worth Mimicking".J Adhesion.81 (3–4):1–21.doi:10.1080/00218460590944602.S2CID 136967853.
- ^"Study Reveals Details Of Mussels' Tenacious Bonds". Science Daily. 16 August 2006. Retrieved30 September 2013.
- ^"Mussel Adhesive Protein Mimetics". Archived fromthe original on 29 May 2006.
- ^Giuri D, Ravarino P, Tomasini C (June 2021). "L-Dopa in small peptides: an amazing functionality to form supramolecular materials".Organic & Biomolecular Chemistry.19 (21):4622–4636.doi:10.1039/D1OB00378J.hdl:11585/840774.PMID 33978030.S2CID 234474122.
- ^Fichman G, Adler-Abramovich L, Manohar S, Mironi-Harpaz I, Guterman T, Seliktar D, et al. (July 2014)."Seamless metallic coating and surface adhesion of self-assembled bioinspired nanostructures based on di-(3,4-dihydroxy-L-phenylalanine) peptide motif".ACS Nano.8 (7):7220–7228.doi:10.1021/nn502240r.PMC 4108209.PMID 24936704.
- ^Fichman G, Guterman T, Adler-Abramovich L, Gazit E (August 2014)."The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies".Nanomaterials.4 (3):726–740.doi:10.3390/nano4030726.PMC 5304689.PMID 28344244.
- ^Fichman G, Andrews C, Patel NL, Schneider JP (October 2021)."Antibacterial Gel Coatings Inspired by the Cryptic Function of a Mussel Byssal Peptide".Advanced Materials.33 (40): e2103677.Bibcode:2021AdM....3303677F.doi:10.1002/adma.202103677.PMC 8492546.PMID 34423482.
- ^Maity S, Nir S, Zada T, Reches M (October 2014). "Self-assembly of a tripeptide into a functional coating that resists fouling".Chemical Communications.50 (76):11154–11157.doi:10.1039/C4CC03578J.PMID 25110984.
- ^Fujii Y, Shibuya T, Yasuda T (1991). "L-3,4-Dihydroxyphenylalanine as an Allelochemical Candidate from Mucuna pruriens (L.) DC. var. utilis".Agricultural and Biological Chemistry.55 (2):617–618.doi:10.1080/00021369.1991.10870627.
- ^Hsieh EJ, Liao SW, Chang CY, Tseng CH, Wang SL, Grillet L (2023)."L-DOPA induces iron accumulation in roots of Ipomoea aquatica and Arabidopsis thaliana in a pH-dependent manner".Botanical Studies.64 (24):617–618.Bibcode:2023BotSt..64...24H.doi:10.1186/s40529-023-00396-7.PMC 10449704.PMID 37620733.
- ^Lucero MT, Farrington H, Gilly WF (August 1994)."Quantification of L-Dopa and Dopamine in Squid Ink: Implications for Chemoreception".The Biological Bulletin.187 (1):55–63.doi:10.2307/1542165.ISSN 1939-8697.PMID 29281314.